WO2011102526A1 - Préparation cosmétique - Google Patents

Préparation cosmétique Download PDF

Info

Publication number
WO2011102526A1
WO2011102526A1 PCT/JP2011/053796 JP2011053796W WO2011102526A1 WO 2011102526 A1 WO2011102526 A1 WO 2011102526A1 JP 2011053796 W JP2011053796 W JP 2011053796W WO 2011102526 A1 WO2011102526 A1 WO 2011102526A1
Authority
WO
WIPO (PCT)
Prior art keywords
acid
component
poe
group
carbon atoms
Prior art date
Application number
PCT/JP2011/053796
Other languages
English (en)
Japanese (ja)
Inventor
祐子 鈴木
隆司 大森
Original Assignee
株式会社資生堂
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社資生堂 filed Critical 株式会社資生堂
Publication of WO2011102526A1 publication Critical patent/WO2011102526A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/26—Optical properties
    • A61K2800/262—Transparent; Translucent

Definitions

  • the present invention relates to cosmetics. More specifically, the present invention relates to a transparent or translucent cosmetic material that is fast to skin, does not sticky when dried, and has excellent formulation stability.
  • Skin cosmetics such as lotion are used for the purpose of imparting appropriate moisture to the skin and keeping the skin healthy.
  • Moisturizers are widely used as moisturizing ingredients, but cosmetics that contain a relatively large amount of water in addition to the moisturizer have a low affinity for the skin when applied and tend to be repelled on the skin. There was a problem that the feeling of penetration was bad.
  • dextran or dextran derivatives are blended (Patent Document 1), and raffinose and agar are combined in a certain amount (Patent Document 2).
  • Patent Document 1 dextran or dextran derivatives are blended
  • raffinose and agar are combined in a certain amount
  • these conventional methods have problems such as safety concerns (skin on the skin, etc.), alcohol odor, and insufficient effects.
  • the present invention has been made in view of the above-described conventional circumstances, and an object thereof is to provide a transparent to translucent cosmetic material that is excellent in speed of familiarity with the skin, non-stickiness when dried, and excellent in formulation stability. .
  • the present invention comprises (a) a silicone-based surfactant represented by the following formula (I) and (b) a block-type alkylene oxide derivative represented by the following formula (II), To provide translucent cosmetics.
  • R 1 represents an alkyl group having 1 to 6 carbon atoms
  • R 2 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms
  • k represents the average number of moles of oxyethylene group added; Represents a number from 3 to 30.
  • Z represents a residue obtained by removing a hydroxyl group from dimer diol; AO represents an oxyalkylene group having 3 to 4 carbon atoms, EO represents an oxyethylene group, and these addition forms are in a block form. is there. a and b are average addition moles of AO and EO, respectively, 1 ⁇ 2 ⁇ a ⁇ 150, 1 ⁇ 2 ⁇ b ⁇ 150, and the total amount of oxyalkylene group having 3 to 4 carbon atoms and oxyethylene group The ratio of oxyethylene groups to 10 to 99% by mass. R 3 represents an alkyl group having 1 to 4 carbon atoms which may be the same or different. ]
  • the present invention also provides the cosmetic described above, wherein the amount of component (a) is 0.01 to 3.0% by mass.
  • the present invention also provides the cosmetic described above, wherein the amount of component (b) is 0.02 to 5.0% by mass.
  • a transparent or translucent cosmetic material that has a fast fit to the skin, no stickiness when dry, and excellent formulation stability.
  • POE represents polyoxyethylene
  • POP represents polyoxypropylene
  • POB represents polyoxybutylene
  • a silicone surfactant represented by the following formula (I) is used as the component (a).
  • each R 1 independently represents an alkyl group having 1 to 6 carbon atoms. A methyl group is preferred.
  • R 2 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms.
  • An alkyl group having 1 to 6 carbon atoms is preferable, and a methyl group is particularly preferable.
  • K is the average number of moles of oxyethylene groups added and represents a number of 3 to 30, preferably 6 to 20.
  • k is the average number of moles of oxyethylene groups added and represents a number of 3 to 30, preferably 6 to 20.
  • k is less than 3, the formulation stability is insufficient.
  • k exceeds 30, the familiarity with the skin is deteriorated.
  • the component (a) can be produced by a conventional method using a known technique. For example, alkyltrisiloxane, one-end alkyl-capped polyoxyalkylene, and the like are reacted (hydrosilylation reaction) in an organic solvent such as isopropyl alcohol. The reaction is carried out under a nitrogen atmosphere under reflux conditions, and chloroplatinic acid or the like is used as the catalyst. The target compound can be obtained by removing the solvent from the reaction solution with a separatory funnel or the like.
  • the component (a) mainly contributes to the speed of familiarity with the skin, and the blending amount thereof is preferably 0.01 to 3.0% by mass, more preferably 0.02 to 2%, based on the total amount of the cosmetic of the present invention. 0.0% by mass. If it is less than 0.01% by mass, it may be difficult to obtain enough to quickly satisfy the skin. It may be difficult to obtain the desired effect and the stability may be affected.
  • the component (b) is a block type alkylene oxide derivative represented by the following formula (II) and is a nonionic surfactant.
  • Z represents a residue obtained by removing a hydroxyl group from dimer diol.
  • it is preferably a dimer diol residue having 24 to 48 carbon atoms.
  • the dimer diol is a diol obtained by reducing dimer acid.
  • a dimer diol residue part is essential in order to make formulation stability favorable.
  • AO represents an oxyalkylene group having 3 to 4 carbon atoms, and specific examples thereof include an oxypropylene group and an oxybutylene group, preferably an oxybutylene group.
  • EO represents an oxyethylene group.
  • the additional form of AO and EO is a block shape. If it is random, the preparation stability is poor.
  • the addition order is preferably such that the dimer diol is bonded in the order of AO and EO.
  • a and b are average added mole numbers of AO and EO, respectively, 1 ⁇ 2 ⁇ a ⁇ 150, 1 ⁇ 2 ⁇ b ⁇ 150.
  • the value of (2 ⁇ a) is less than 1 or more than 150, the preparation stability tends to be inferior. If the value of (2 ⁇ b) is less than 1, the formulation stability tends to be inferior.
  • the ratio of the oxyethylene group to the total amount of the oxyalkylene group having 3 to 4 carbon atoms and the oxyethylene group is 10 to 99% by mass, preferably 20 to 70% by mass. If the amount is less than 10% by mass, the preparation stability tends to be inferior. On the other hand, if the amount exceeds 99% by mass, satisfactory results cannot be obtained in the absence of stickiness when dried.
  • R 3 represents an alkyl group having 1 to 4 carbon atoms which may be the same or different. When the number of carbon atoms is 5 or more, the preparation stability tends to be inferior. Specific examples of the alkyl group having 1 to 4 carbon atoms include methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, sec-butyl group, tert-butyl group, and mixed groups thereof. Is mentioned. In the present invention, a methyl group and an ethyl group are preferable.
  • the dimer acid used as the raw material of the dimer diol for example, a dimer obtained by polymerizing a higher unsaturated fatty acid or a lower alcohol ester thereof is preferably used. Specifically, it can be synthesized by a method in which a higher unsaturated fatty acid or an ester of these lower alcohols is reacted by thermal polymerization such as Diels-Alder reaction, or other reaction methods. In the produced dimer acid, unreacted fatty acids may remain as long as the effects of the present invention are not impaired.
  • the dimer acid is preferably a dimerized higher unsaturated fatty acid having 12 to 24 carbon atoms or a lower alcohol ester thereof.
  • Z is a dimer diol residue having 24 to 48 carbon atoms.
  • Such higher unsaturated fatty acids include myristoleic acid, palmitoleic acid, oleic acid, elaidic acid, vaccenic acid, gadoleic acid, erucic acid, nervonic acid, linoleic acid, linolenic acid and those having 1 to 3 carbon atoms. And lower alcohol esters.
  • unsaturated fatty acids having 18 carbon atoms or lower alcohol esters thereof and oleic acid and linoleic acid or lower alcohol esters thereof are particularly preferred.
  • dimer acid obtained by hydrogenating the remaining unsaturated double bond after dimerization may be used. Dimer diol is obtained by reducing these dimer acids.
  • Dimer diols are commercially available from animal oils and vegetable oils, and these can be used. Although all can be used in this invention, the thing derived from vegetable oil is more preferable. Examples of such dimer diols include “Sovermol® 908” (manufactured by Cognis Japan), “PRIPOL® 2033” (manufactured by Unikema), “Pespol HP-1000” (manufactured by Toagosei Co., Ltd.), and the like.
  • a component can be manufactured by a well-known method. For example, it can be obtained by subjecting dimer diol to addition polymerization of an alkylene oxide having 3 to 4 carbon atoms and ethylene oxide in this order, and then subjecting an alkyl halide to an ether reaction in the presence of an alkali catalyst. However, it is not limited to this manufacturing method.
  • the component (b) specifically, for example, POB (25) POE (34) dimethyl dimer diol ether, POB (25) POE (35) dimethyl dimer diol ether, POB (4) POE (13 ) Dimethyl dimer diol ether, POB (25) POE (52) Dimethyl dimer diol ether, POB (18) POE (41) Dimethyl dimer diol ether, POB (18) POE (41) Diethyl dimer diol ether, POB (18) POE (41) Dipropyl dimer diol ether, POB (18) POE (41) dibutyl dimer diol ether, POB (11) POE (30) dimethyl dimer diol ether, POB (15) POE (44) dimethyl dimer diol -TEB, POB (18) POE (50) dimethyl dimer diol ether, POB (21) POE (56) dimethyl dimer diol ether, POB (12) POE (50) dimethyl dimer diol
  • the added moles of POE, POP, and POB are the total added moles in the molecule, that is, POE is expressed as a value of (2 ⁇ b), and POP and POB are values of (2 ⁇ a). It is written as.
  • the component (b) contributes mainly to the translucent to transparent appearance and stability, and the non-stickiness upon drying, and the blending amount thereof is 0.02 to 5.0% by mass in the total amount of the cosmetic of the present invention. Preferably, it is 0.05 to 4.0% by mass. If the amount is less than 0.02% by mass, the effect may not be sufficiently obtained. On the other hand, if the amount exceeds 5.0% by mass, the familiarity with the skin tends to deteriorate.
  • a) component / (b) component 1/500 to 100/1 (mass ratio), more preferably 1 / 300 to 80/1 (mass ratio).
  • the water-based cosmetics as described above are excellent in the speed of familiarity with the skin and the non-stickiness when dry, It is excellent in the stability of the preparation and can produce an excellent effect that a transparent or translucent appearance can be obtained.
  • “transparent to translucent” refers to those having a transparency in the range of 20 to 100 when the transparency of the purified water is 100 and the case where no light is transmitted is 0.
  • the milky milky emulsion has a transparency of 15 or less.
  • the transparency can be measured by a conventional method, for example, using a digital colorimetric color difference calculator (manufactured by Suga Test Instruments Co., Ltd.).
  • a moisturizer and surfactant usually incorporated as a base in cosmetics, in addition to the above components, within the range not impairing the effects of the present invention
  • Amphoteric surfactants, nonionic surfactants, etc. oils (hydrocarbon oils, synthetic ester oils, silicone oils, liquid fats, solid fats, waxes, etc.), higher fatty acids, higher alcohols, powder components, high water solubility Molecule (natural, semi-synthetic, synthetic), thickener, UV absorber, sequestering agent, lower alcohol, saccharide (monosaccharide, oligosaccharide, polysaccharide), organic amine, pH adjuster, vitamins, antioxidant Antioxidant assistants, other components that can be blended, and the like can be blended as necessary.
  • humectant examples include polyglycerin such as glycerin, diglycerin, triglycerin, tetraglycerin, ethylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, propylene glycol, dipropylene glycol, polyethylene glycol, 1, Examples include 3-propanediol, glucose, maltose, maltitol, sucrose, fructose, xylitol, sorbitol, maltotriose, threitol, erythritol, amylolytic sugar-reducing alcohol, polyglycerin derivative, polyoxyalkylene alkyl glucoside and the like.
  • polyglycerin such as glycerin, diglycerin, triglycerin, tetraglycerin, ethylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, propylene glycol, dipropylene glycol, polyethylene
  • glycerin diglycerin, 1,3-butylene glycol, 1,4-butylene glycol, dipropylene glycol, polyethylene glycol, xylitol, erythritol, and sorbitol are particularly preferable.
  • Anionic surfactants include, for example, fatty acid soaps (eg, sodium laurate, sodium palmitate, etc.); higher alkyl sulfates (eg, sodium lauryl sulfate, potassium lauryl sulfate, etc.); alkyl ether sulfates (eg, POE lauryl sulfate triethanolamine, POE sodium lauryl sulfate, etc.); N-acyl sarcosine acid (eg, lauroyl sarcosine sodium, etc.); higher fatty acid amide sulfonates (eg, N-myristoyl-N-methyl taurine sodium, coconut oil fatty acid) Methyl tauride sodium, lauryl methyl tauride sodium, etc.); Phosphate ester salts (POE oleyl ether sodium phosphate, POE stearyl ether phosphate, etc.); Sulfosuccinate (eg, -2-sodium
  • Examples of the cationic surfactant include alkyltrimethylammonium salts (eg, stearyltrimethylammonium chloride, lauryltrimethylammonium chloride, etc.); alkylpyridinium salts (eg, cetylpyridinium chloride, etc.); distearyldimethylammonium dialkyldimethylammonium chloride; Poly (N, N'-dimethyl-3,5-methylenepiperidinium chloride); alkyl quaternary ammonium salt; alkyldimethylbenzylammonium salt; alkylisoquinolinium salt; dialkyl morpholinium salt; POE alkylamine; Examples include amine salts; polyamine fatty acid derivatives; amyl alcohol fatty acid derivatives; benzalkonium chloride; benzethonium chloride and the like.
  • alkyltrimethylammonium salts eg, stearyltrimethylammonium chloride, lauryltrimethylammonium
  • amphoteric surfactants examples include imidazoline-based amphoteric surfactants (eg, 2-undecyl-N, N, N- (hydroxyethylcarboxymethyl) -2-imidazoline sodium, 2-cocoyl-2-imidazolinium hydroxide). Side-1-carboxyethyloxy disodium salt, etc.); betaine surfactants (for example, 2-heptadecyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, lauryldimethylaminoacetic acid betaine, alkylbetaine, amide betaine) , Sulfobetaine, etc.).
  • imidazoline-based amphoteric surfactants eg, 2-undecyl-N, N, N- (hydroxyethylcarboxymethyl) -2-imidazoline sodium, 2-cocoyl-2-imidazolinium hydroxide).
  • hydrophilic nonionic surfactants include POE sorbitan fatty acid esters (eg, POE sorbitan monooleate, POE sorbitan monostearate, POE sorbitan tetraoleate); POE sorbite fatty acid esters (eg, POE sorbit) Monolaurate, POE sorbite monooleate, POE sorbite pentaoleate, POE sorbite monostearate, etc.); POE glycerin fatty acid esters (for example, POE glycerin monostearate, POE glycerin monoisostearate, POE glycerin triisostearate) POE monooleate such as a rate); POE fatty acid esters (eg, POE distearate, POE monodiolate, ethylene glycol distearate, etc.); P E alkyl ethers (for example, POE lauryl ether, POE o
  • hydrocarbon oil examples include liquid paraffin, isododecane, isohexadecane, squalane, pristane, paraffin, ceresin, squalene, petrolatum, microcrystalline wax, and the like.
  • Synthetic ester oils include isopropyl myristate, cetyl octanoate, octyldodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyl decyl dimethyloctanoate, cetyl lactate, myristyl lactate , Isocetyl stearate, isocetyl isostearate, ethylene glycol di-2-ethylhexanoate, dipentaerythritol fatty acid ester, N-alkyl glycol monoisostearate, neopentyl glycol dicaprate, diisostearyl malate, di-2-heptyl Glycerin undecanoate, tri-2-ethylhexanoic acid trimethylolpropane, triisostearic acid tri
  • silicone oil examples include linear polysiloxanes (for example, dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane, etc.); cyclic polysiloxanes (for example, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexyl).
  • silicone resins that form a three-dimensional network structure various modified polysiloxanes (amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, fluorine-modified polysiloxane, etc.) It is done.
  • liquid fats examples include avocado oil, camellia oil, macadamia nut oil, corn oil, olive oil, rapeseed oil, sesame oil, persic oil, wheat germ oil, sasanqua oil, castor oil, linseed oil, safflower oil, cottonseed oil, eno oil , Soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, snail oil, Japanese drill oil, jojoba oil, germ oil and the like.
  • solid fat examples include cocoa butter, coconut oil, hardened coconut oil, palm oil, palm kernel oil, owl kernel oil, hardened oil, owl, and hardened castor oil.
  • waxes examples include beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, ibota wax, montan wax, nukarou, kapok wax, sugar cane wax, jojoballow, shellac wax, and the like.
  • higher fatty acids examples include lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, undecylenic acid, toluic acid, isostearic acid, linoleic acid, linolenic acid, eicosapentaenoic acid (EPA), docosahexaenoic acid ( DHA) and the like.
  • higher alcohols examples include linear alcohols (eg, lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, cetostearyl alcohol); branched chain alcohols (eg, monostearyl glycerin ether (batyl alcohol) ), 2-decyltetradecinol, phytosterol, hexyldodecanol, isostearyl alcohol, octyldodecanol and the like.
  • linear alcohols eg, lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, cetostearyl alcohol
  • branched chain alcohols eg, monostearyl glycerin ether (batyl alcohol)
  • 2-decyltetradecinol eg., phytosterol, hexyldodecanol, isostearyl alcohol, o
  • the powder component examples include inorganic powders (for example, talc, kaolin, mica, sericite (sericite), muscovite, phlogopite, synthetic mica, saucite, biotite, permiculite, magnesium carbonate, calcium carbonate, silicic acid.
  • inorganic powders for example, talc, kaolin, mica, sericite (sericite), muscovite, phlogopite, synthetic mica, saucite, biotite, permiculite, magnesium carbonate, calcium carbonate, silicic acid.
  • Red No. 104 Red No. 106, Red No. 227, Red No. 230, Red No. 401, Red No. 505, Orange No. 205, Yellow No. 4, Yellow No. 5, Yellow No. 202, Yellow No. 203, Green No. 3 and Blue No. 1
  • natural pigments for example, chlorophyll, ⁇ -carotene, etc.
  • water-soluble polymers examples include gum arabic, gum tragacanth, galactan, guar gum, locust bean gum, tamarind gum, carob gum, caraya gum, carrageenan, pectin, agar, quince seed (malmello), alge colloid (gypsum extract), starch (rice, corn, Potato, wheat), plant water-soluble polymers such as glycyrrhizic acid; microbial water-soluble polymers such as xanthan gum, dextran, succinoglycan, and bullulan; animal water-soluble polymers such as collagen, casein, albumin, and gelatin; Starch-based water-soluble polymers such as carboxymethyl starch and methylhydroxypropyl starch; methylcellulose, nitrocellulose, ethylcellulose, methylhydroxypropylcellulose, hydroxyethyl Cellulose water-soluble polymers such as cellulose cellulose, sodium cellulose sulfate, hydroxypropyl cellulose, carboxymethyl cellulose
  • ultraviolet absorber examples include benzoic acid-based ultraviolet absorbers (for example, paraaminobenzoic acid (hereinafter abbreviated as PABA), PABA monoglycerin ester, N, N-dipropoxy PABA ethyl ester, N, N-diethoxy PABA ethyl ester.
  • PABA paraaminobenzoic acid
  • PABA monoglycerin ester N, N-dipropoxy PABA ethyl ester
  • N, N-diethoxy PABA ethyl ester examples include benzoic acid-based ultraviolet absorbers (for example, paraaminobenzoic acid (hereinafter abbreviated as PABA), PABA monoglycerin ester, N, N-dipropoxy PABA ethyl ester, N, N-diethoxy PABA ethyl ester.
  • PABA paraaminobenzoic acid
  • sequestering agent examples include 1-hydroxyethane-1,1-diphosphonic acid, 1-hydroxyethane-1,1-diphosphonic acid tetrasodium salt, disodium edetate, trisodium edetate, and tetrasodium edetate. , Sodium citrate, sodium polyphosphate, sodium metaphosphate, gluconic acid, edetic acid, trisodium ethylenediaminehydroxyethyl triacetate and the like.
  • lower alcohols examples include ethanol, propanol, isopropanol, isobutyl alcohol, t-butyl alcohol and the like.
  • Monosaccharides include, for example, tricarbon sugars (eg, D-glyceryl aldehyde, dihydroxyacetone, etc.); tetracarbon sugars (eg, D-erythrose, D-erythrulose, D-treose, erythritol, etc.); pentose sugars (eg, L-arabinose, D-xylose, L-lyxose, D-arabinose, D-ribose, D-ribulose, D-xylulose, L-xylulose, etc .; hexose (eg, D-glucose, D-talose, D) -Bucicose, D-galactose, D-fructose, L-galactose, L-mannose, D-tagatose, etc.); pentose sugar (eg, aldheptose, heproose, etc.); octo
  • oligosaccharides examples include guanthianose, umbelliferose, lactose, planteose, isoliquinoses, ⁇ , ⁇ -trehalose, raffinose, lycnose, umbilicin, stachyose verbus courses and the like.
  • polysaccharide examples include chondroitin sulfate, dermatan sulfate, glycogen, heparan sulfate, hyaluronic acid, keratan sulfate, chondroitin, mucoitin sulfate, keratosulfuric acid, succinoglucan, and caronic acid.
  • amino acids examples include neutral amino acids (eg, threonine, cysteine, etc.); basic amino acids (eg, hydroxylysine, etc.), and the like.
  • amino acid derivatives include acyl sarcosine sodium (lauroyl sarcosine sodium), acyl glutamate, acyl ⁇ -alanine sodium, glutathione, pyrrolidone carboxylic acid and the like.
  • organic amines examples include monoethanolamine, diethanolamine, triethanolamine, morpholine, triisopropanolamine, 2-amino-2-methyl-1,3-propanediol, and 2-amino-2-methyl-1-propanol. Is mentioned.
  • pH adjuster examples include buffers such as lactic acid-sodium lactate, citric acid-sodium citrate, and succinic acid-sodium succinate.
  • vitamins examples include vitamins A, B1, B2, B6, C, E and derivatives thereof, pantothenic acid and derivatives thereof, biotin and the like.
  • antioxidants examples include tocopherols, dibutylhydroxytoluene, butylhydroxyanisole, gallic acid esters and the like.
  • antioxidant assistant examples include phosphoric acid, citric acid, ascorbic acid, maleic acid, malonic acid, succinic acid, fumaric acid, kephalin, hexametaphosphate, phytic acid, ethylenediaminetetraacetic acid and the like.
  • ingredients that can be blended include, for example, preservatives (phenoxyethanol, ethylparaben, etc.); anti-inflammatory agents (eg, glycyrrhizic acid derivatives, glycyrrhetinic acid derivatives, salicylic acid derivatives, hinokitiol, zinc oxide, allantoin, etc.); whitening agents (for example, (Yukinoshita extract, arbutin, etc.); various extracts (for example, buckwheat, auren, shikon, peonies, assembly, birch, sage, loquat, carrot, aloe, mallow, iris, grape, yokuinin, loofah, lily, saffron, nematode, Ginger, hypericum, onion, garlic, red pepper, chimney, red pepper, seaweed, etc., activator (eg, royal jelly, photosensitizer, etc.); blood circulation promoter (eg, nonyl acid wallenyl
  • the dosage form of the cosmetic of the present invention is not particularly limited as long as it can be applied to the skin, and examples thereof include skin lotion, lotion, and an impregnating liquid impregnated into a sheet-like base.
  • Example 1 Samples 1 to 12 shown in Table 1 below were prepared. Each sample was prepared by mixing the components corresponding to (1) to (11) and separately adding this to the mixture of (12) and (13).
  • Samples 7 to 12 satisfying the constituent requirements of the present invention are translucent to transparent, formulation stability, quickness to skin, and no stickiness when dry. Excellent effect was obtained.
  • Samples 1 to 6 that do not satisfy the constituent requirements of the present invention could not have all the effects of the present invention.
  • sample 1 did not contain both component (a) and component (b), and the stability of the preparation, the speed of familiarity with the skin, and the lack of stickiness when dried were not sufficient.
  • Sample 2 contained the component (b) but did not contain the component (a), and the speed of familiarity with the skin was not sufficient.
  • Sample 3 contained the component (a) but did not contain the component (b), did not give a transparent or translucent appearance, was inferior in the stability of the preparation, and was not sufficient in the non-stickiness upon drying.
  • sample 4 when other nonionic surfactant was used instead of the component (b), the stability of the preparation and the non-stickiness upon drying were not sufficient.
  • Samples 5 and 6 when other silicone surfactants were used in place of the component (a), sufficient speed of familiarity with the skin could not be obtained.
  • a transparent or translucent cosmetic material that has a fast fit to the skin, no stickiness when dry, and excellent formulation stability.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

L'invention porte sur une préparation cosmétique transparente ou translucide qui présente une excellente compatibilité avec la peau et une excellente stabilité de la préparation, tout en étant exempte de caractère collant au moment du séchage. Plus précisément, l'invention porte sur une préparation cosmétique transparente ou translucide qui contient (a) un tensio-actif siliconé représenté par la formule (I) et (b) un dérivé à blocs d'oxyde d'alkylène représenté par la formule (II). (Dans la formule (I), R1 représente un groupe alkyle en C1-6 ; R2 représente H ou un groupe alkyle en C1-6 ; et k représente un nombre de 3 à 30). (Dans la formule (II), Z représente un résidu qui est obtenu par élimination d'un groupe hydroxy à partir d'un diol dimère ; AO représente un groupe oxyalkylène en C3-4, EO représente un groupe oxyéthylène, et AO et EO sont ajoutés sous forme de blocs ; a et b satisfont à 1 ≤ 2 × a ≤ 150 et 1 ≤ 2 × b ≤ 150, et le rapport des groupes oxyéthylène au nombre total des groupes oxyalkylène en C3-4 et des groupes oxyéthylène est de 10 à 99 % en masse ; et R3 représente un groupe alkyle en a C1-4.)
PCT/JP2011/053796 2010-02-22 2011-02-22 Préparation cosmétique WO2011102526A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010-035655 2010-02-22
JP2010035655A JP2013079197A (ja) 2010-02-22 2010-02-22 化粧料

Publications (1)

Publication Number Publication Date
WO2011102526A1 true WO2011102526A1 (fr) 2011-08-25

Family

ID=44483109

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2011/053796 WO2011102526A1 (fr) 2010-02-22 2011-02-22 Préparation cosmétique

Country Status (2)

Country Link
JP (1) JP2013079197A (fr)
WO (1) WO2011102526A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013203732A (ja) * 2012-03-29 2013-10-07 Shiseido Co Ltd 水中油型乳化皮膚化粧料

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05155749A (ja) * 1991-12-11 1993-06-22 Kao Corp 化粧水
US6074633A (en) * 1996-03-21 2000-06-13 L'oreal Detergent cosmetic composition containing an oxyalkylenated silicone
JP2000508373A (ja) * 1997-01-14 2000-07-04 ロレアル 濃化水性組成物及び使用
JP2008247859A (ja) * 2007-03-30 2008-10-16 Nof Corp 化粧料組成物
JP2009029909A (ja) * 2007-07-26 2009-02-12 Shiseido Co Ltd アルキレンオキシド誘導体及びこれを含有する皮膚外用剤

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05155749A (ja) * 1991-12-11 1993-06-22 Kao Corp 化粧水
US6074633A (en) * 1996-03-21 2000-06-13 L'oreal Detergent cosmetic composition containing an oxyalkylenated silicone
JP2000508373A (ja) * 1997-01-14 2000-07-04 ロレアル 濃化水性組成物及び使用
JP2008247859A (ja) * 2007-03-30 2008-10-16 Nof Corp 化粧料組成物
JP2009029909A (ja) * 2007-07-26 2009-02-12 Shiseido Co Ltd アルキレンオキシド誘導体及びこれを含有する皮膚外用剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013203732A (ja) * 2012-03-29 2013-10-07 Shiseido Co Ltd 水中油型乳化皮膚化粧料

Also Published As

Publication number Publication date
JP2013079197A (ja) 2013-05-02

Similar Documents

Publication Publication Date Title
KR102402508B1 (ko) 고형 분말 화장료
JP5277011B2 (ja) 水中油型乳化白濁皮膚化粧料
JP5230975B2 (ja) アルキレンオキシド誘導体及びこれを含有する皮膚外用剤
JP5305574B2 (ja) 皮膚外用剤
JP5203735B2 (ja) 毛髪化粧料
WO2018074149A1 (fr) Composition d'agent nettoyant
JP2009242321A (ja) 皮膚外用剤
JP2010024159A (ja) 微細エマルション組成物、およびその製造方法
JP5121527B2 (ja) 皮膚外用剤
JPWO2018088570A1 (ja) 皮膚外用剤組成物
JP2010024161A (ja) 微細エマルション組成物、およびその製造方法
JP2010275206A (ja) 化粧料
JP2005272454A (ja) 皮膚外用剤
JP5154904B2 (ja) 皮膚外用剤
JP4349883B2 (ja) 皮膚外用組成物
WO2011102526A1 (fr) Préparation cosmétique
JP4956317B2 (ja) 皮膚洗浄料
CN112714643A (zh) 油包水型皮肤外用组合物
JP3660627B2 (ja) パック化粧料
WO2011065123A1 (fr) Produit cosmétique
JP2006045133A (ja) 水中油型乳化組成物
JP3865032B2 (ja) メーキャップ化粧料
JP2010100555A (ja) ゲル状組成物
JP5095187B2 (ja) 毛髪コンディショニング組成物
JP2009029739A (ja) 浴用剤組成物

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11744812

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11744812

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP